Keros Therapeutics
KROS
KROS
129 hedge funds and large institutions have $937M invested in Keros Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 50 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 125 → 129 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less capital invested
Capital invested by funds: $948M → $937M (-$11.2M)
Holders
129
Holding in Top 10
4
Calls
$2.16M
Puts
$4K
Top Buyers
| 1 | +$39.7M | |
| 2 | +$23.7M | |
| 3 | +$22.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.9M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$12.8M |
Top Sellers
| 1 | -$17M | |
| 2 | -$13.4M | |
| 3 | -$6.7M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.49M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.8M |